Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine–Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors-Reference-Cited by-同舟云学术

Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine–Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors

Published:2022-01 Issue: Volume:228 Page:114004
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Abdel-Mohsen Heba T.,El Kerdawy Ahmed M.,Omar Mohamed A.,Petreni Andrea,Allam Rasha M.,El Diwani Hoda I.,Supuran Claudiu T.^ORCID

Funder

National Research Centre

National Cancer Institute

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference54 articles.

1. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;Ca - Cancer J. Clin.,2021

2. Tumor angiogenesis: causes, consequences, challenges and opportunities;Lugano;Cell. Mol. Life Sci.,2020

3. Tumor Cells and the Onset of Cancer, Molecular Cell Biology;Lodish,2000

4. Tumor hypoxia and malignant progression;Osinsky;Exp. Oncol.,2009

5. Tumor hypoxia and malignant progression;Vaupel;Methods Enzymol.,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of new sulfonamide derivatives: Investigation of their interactions with carbonic anhydrase and cholinesterase enzymes by in vitro and in silico evaluations;Journal of Molecular Structure;2024-10

2. A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments;European Journal of Medicinal Chemistry;2024-08

3. Tail‐approach based design, synthesis, and molecular modeling of benzenesulfonamides carrying thiadiazole and urea moieties as novel carbonic anhydrase inhibitors;Archiv der Pharmazie;2024-07-30

4. Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity;Archiv der Pharmazie;2024-07-23

5. Quinazoline‐oxindole hybrids as angiokinase inhibitors and anticancer agents: Design, synthesis, biological evaluation, and molecular docking studies;Archiv der Pharmazie;2024-07-12